Loading company…
Orpha Biotech develops potential treatments for rare diseases.
Orpha Biotech develops solutions for rare diseases where treatments may not exist, focusing on molecular drivers and biological mechanisms. Its small-molecule platform is intended to produce potential agonist or antagonist NCEs for a range of conditions. The company was founded in 2018 in Lecce, Italy. In July 2020, it received Seed funding from CDP Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in